Quadrature Capital’s Natus Medical Inc NTUS Stock Holding History

Quadrature Capital’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,865	Closed	-$306K	–	1136
2020 Q3	$306K	Buy	+17,865	New	+$338K	0.02%	568

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quadrature Capital's NTUS Position: Q4 2020 in Review

Quadrature Capital sold out of Natus Medical Inc (NTUS) in Q4 2020, closing a stake of 17,865 shares — an estimated $306K sold.

Quadrature Capital first reported a position in NTUS in Q3 2020 and held it in 1 quarter. The position peaked at $306K in Q3 2020. 163 funds tracked by Wall St. Rank hold NTUS as of Q4 2020.

Quadrature Capital reported no remaining Natus Medical Inc position as of Q4 2020 after selling out during the quarter.
Quadrature Capital sold 17,865 Natus Medical Inc shares in Q4 2020, an estimated $306K.
Quadrature Capital first reported a position in Natus Medical Inc in Q3 2020 and held it in 1 quarter.
Quadrature Capital's Natus Medical Inc position peaked at $306K in Q3 2020.
163 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2020.

Based on Quadrature Capital's 13F filing for Q4 2020, filed 16 Feb 2021.